Exact Mass: 765.3989

Exact Mass Matches: 765.3989

Found 26 metabolites which its exact mass value is equals to given mass value 765.3989, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

ABT-773

(1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-13-ethyl-2,4,6,8,10,14-hexamethyl-6-[(E)-3-(3-quinolyl)allyloxy]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone

C42H59N3O10 (765.42)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

Biomer

pentyl 2-[4-({4-[({4-[({4-[(4-{[(pentyloxy)carbonyl]amino}phenyl)methyl]phenyl}carbamoyl)oxy]butoxy}carbonyl)amino]phenyl}methyl)phenyl]acetate

C45H55N3O8 (765.3989)

D001697 - Biomedical and Dental Materials > D001672 - Biocompatible Materials

Abbott-195773

10-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-4-ethyl-3a,7,9,11,13,15-hexamethyl-11-{[3-(quinolin-3-yl)prop-2-en-1-yl]oxy}-tetradecahydro-1H-oxacyclotetradeca[4,3-d][1,3]oxazole-2,6,8,14-tetrone

C42H59N3O10 (765.42)

L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-

2-[1-(1-{2-[2-(5-aminopentanamido)-3-phenylpropanamido]-3-phenylpropanoyl}pyrrolidin-2-yl)-N-methylformamido]-N-[1-carbamoyl-3-(methylsulfanyl)propyl]-4-methylpentanamide

C40H59N7O6S (765.4247)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C784 - Protein Synthesis Inhibitor > C261 - Macrolide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-

2-[1-(1-{2-[2-(5-aminopentanamido)-3-phenylpropanamido]-3-phenylpropanoyl}pyrrolidin-2-yl)-N-methylformamido]-N-[1-carbamoyl-3-(methylsulfanyl)propyl]-4-methylpentanamide

C40H59N7O6S (765.4247)

Desferricoprogen(3-)

C35H53N6O13-3 (765.367)

8-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-9-[(E)-3-quinolin-3-ylprop-2-enoxy]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone

C42H59N3O10 (765.42)

PC 20:5/12:3;O3

C40H64NO11P (765.4217)

PC 32:8;O3

C40H64NO11P (765.4217)

LNAPS 34:7;O

C40H64NO11P (765.4217)

PS 20:4/13:4;O2

C39H60NO12P (765.3853)

PS 20:5/13:3;O2

C39H60NO12P (765.3853)

PS 22:4/12:3;O

C40H64NO11P (765.4217)

PS 33:8;O2

C39H60NO12P (765.3853)

PS 34:7;O

C40H64NO11P (765.4217)

SHexCer 34:8;O2

C40H63NO11S (765.4122)

GR-73632

C40H59N7O6S (765.4247)

GR-73632 is a novel tachykinin neurokinin 1 (NK-1) receptor agonist[1]. GR-73632 acts directly on the peripheral terminals of primary sensory neurons through NK1 receptor which convey itch signals[2].

(2e,4e,6e,8e)-9-(4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-9-(4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid

C38H51N7O10 (765.3697)

2-[2-({6-[(3,4-dicarboxybutanoyl)oxy]-11,16,17,18-tetrahydroxy-19-[(1-hydroxyethylidene)amino]-5,9-dimethylnonadecan-7-yl}oxy)-2-oxoethyl]butanedioic acid

C35H59NO17 (765.3783)

2-[5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-15-[9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]ethanimidic acid

2-[5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-15-[9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]ethanimidic acid

C38H51N7O10 (765.3697)

2-[5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-15-[9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]ethanimidic acid

2-[5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-15-[9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl]ethanimidic acid

C38H51N7O10 (765.3697)

(2e,4e,6e,8e)-n-[(3s,6s,9s,12s,15s,16r)-3-[(2r)-butan-2-yl]-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e)-n-[(3s,6s,9s,12s,15s,16r)-3-[(2r)-butan-2-yl]-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]-9-(4-hydroxyphenyl)nona-2,4,6,8-tetraenimidic acid

C38H51N7O10 (765.3697)